HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement Firm Hi-Tech Pays For Another Round Of Refunds In FTC’s 15-Year Litigation

Executive Summary

FTC is mailing 143,636 refund checks totaling more than $8.5m to consumers who bought three supplements marketed with false and misleading advertising by Hi-Tech Pharmaceuticals and several related companies.

You may also be interested in...



As Hi-Tech Argues For DMHA Use, DMAA Seizure Falls In FDA's Criminal Case, Contempt Stands In FTC Complaint

Hi-Tech Pharmaceuticals granted motion in federal court to have $19m in seized DMAA products returned, though the order noted sales of the products are prohibited. As Hi-Tech seeks court order that FDA is wrong about DMAA, an appellate court upholds $40m contempt fine against firm in FTC complaint.

Wheat, Hi-Tech Fined $40M For Violating Court Order On FTC Complaint

Following his recent arrest in a separate federal enforcement, Hi-Tech Pharmaceuticals CEO Jared Wheat and his firm are fined $40m for violating a 2008 court order on an FTC complaint about fraudulent weight loss claims. The financial sanction is justified by a “pattern of contemptuous conduct,” the judge said.

Hi-Tech CEO Wheat Arrested In FDA Investigation Of Steroid-Spiked Supplements

Hi-Tech Pharmaceuticals CEO Jared Wheat and an associate face 18 criminal charges in federal court alleging they falsified FDA documents and distributed as supplements products containing steroid ingredient. Wheat is appealing the indictment to federal circuit court.

Related Content

Topics

UsernamePublicRestriction

Register

PS142249

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel